Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism

D Panas1, F H Khadour, C Szabó

  • 1Departments of Pediatrics and Pharmacology, Cardiovascular Research Group, University of Alberta, Edmonton, Alberta, Canada T6G 2S2.

Insights

Cytomix, a mix of inflammatory cytokines, reduces heart contractile work by increasing inducible nitric oxide synthase (iNOS). This mechanism impairs cardiac efficiency, suggesting NO/peroxynitrite affect ATP utilization rather than mitochondrial respiration.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Inflammation and Immunity

Background:

  • Proinflammatory cytokines (Cytomix) can depress myocardial contractile function.
  • Nitric oxide (NO) and peroxynitrite are known to inhibit myocardial oxygen consumption (MVO2).
  • The precise mechanism by which cytokines impair cardiac work, particularly concerning NO/peroxynitrite and mitochondrial function, requires further elucidation.

Purpose of the Study:

  • To investigate whether NO and peroxynitrite contribute to cytokine-induced depression of cardiac work.
  • To examine the role of inducible nitric oxide synthase (iNOS) in mediating these effects.
  • To determine if NO/peroxynitrite impair cardiac function by inhibiting mitochondrial respiration or by affecting ATP utilization for contractile work.

Main Methods:

  • Isolated working rat heart model subjected to Cytomix treatment.
  • Measurement of cardiac work, myocardial oxygen consumption (MVO2), and cardiac efficiency.
  • Assessment of iNOS expression and inhibition using mercaptoethylguanidine (MEG) and dexamethasone (Dex).

Main Results:

  • Cytomix significantly depressed cardiac work and efficiency, with reduced MVO2 observed later.
  • MEG and Dex abolished the cardiac depression induced by Cytomix.
  • Cytomix increased iNOS expression 10-fold, an effect abolished by Dex but not MEG.
  • Cardiac work depression by Cytomix preceded the reduction in MVO2.

Conclusions:

  • Cytokine-induced cardiac dysfunction involves the stimulation of iNOS.
  • The findings suggest that NO and/or peroxynitrite impair cardiac function by reducing the heart's ability to utilize ATP for contractile work, rather than by inhibiting mitochondrial respiration.
  • This highlights a novel mechanism of inflammatory cardiomyopathy.

Related Concept Videos

Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...